Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015
Maria Dolores Fernandez-Garcia

, Manasi Majumdar, Ousmane Kebe, Aichatou D. Fall, Moussa Kone, Mouctar Kande, Moustapha Dabo, Mohamed Salif Sylla, Djenou Sompare, Wayne Howard, Ousmane Faye, Javier Martin
1, and Kader Ndiaye
1
Author affiliations: Institut Pasteur, Dakar, Senegal (M.D. Fernandez-Garcia, O. Kebe, A.D. Fall, O. Faye, K. Ndiaye); National Institute for Biological Standards and Control, Potters Bar, UK (M. Majumdar, J. Martin); World Health Organization, Conakry, Guinea (M. Kone, M. Kande); Guinean Ministry of Health, Conakry (M. Dabo, M.S. Sylla, D. Sompare); National Institute for Communicable Diseases, Johannesburg, South Africa (W. Howard)
Main Article
Table 4
Frequency of samples, AFP cases, contacts, cVDPVs isolated, NPEV cases, and Sabin-like poliovirus cases in Guinea, 2012–2016*
Year |
No. fecal samples received |
No. AFP cases |
No. contacts |
No. cVDPVs isolated from case-patients |
No. cVDPVs isolated from contacts |
No. NPEV-positive cases |
No. Sabin-like polioviruses |
2012 |
366 |
185 |
0 |
0 |
0 |
23 |
12 |
2013 |
446 |
223 |
0 |
0 |
0 |
21 |
29 |
2014 |
258 |
132 |
0 |
1 |
0 |
22 |
1 |
2015 |
453 |
113 |
119 |
5 |
7 |
40 |
37 |
2016
|
3,580
|
1,298
|
507
|
0
|
0
|
363
|
182
|
*AFP, acute flaccid paralysis; cVDPV, circulating vaccine-derived poliovirus; NPEV, nonpolio enterovirus. |
Main Article
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.